NCT06648057 2026-03-18
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Recruiting
CHA University
Fudan University
German Cancer Research Center
Institut National de la Santé Et de la Recherche Médicale, France
CHA University
German Cancer Research Center